Page last updated: 2024-12-06

fenoxycarb

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Fenoxycarb is a synthetic insecticide belonging to the juvenile hormone analog (JHA) class. It disrupts the normal development of insects, preventing them from reaching adulthood. Fenoxycarb is widely used in agriculture, forestry, and public health to control a variety of insect pests. It is considered to be relatively safe for mammals and birds. Fenoxycarb is synthesized through a series of chemical reactions, starting with the reaction of 2-chloro-4-nitrophenol with 2-methyl-1-propanol. The resulting compound is then reacted with various other chemicals to yield the final product. Fenoxycarb acts by mimicking the effects of juvenile hormone, which is a naturally occurring insect hormone. When insects are exposed to fenoxycarb, it disrupts their normal developmental processes, preventing them from reaching adulthood and reproducing. This makes fenoxycarb an effective insecticide against a wide range of pests. Fenoxycarb is studied for its potential to control a variety of insect pests, including mosquitoes, flies, and agricultural pests. It is also being investigated for its potential to control the spread of diseases such as malaria and dengue fever. Fenoxycarb is relatively safe for mammals and birds, making it a valuable tool for insect control. However, it is important to use fenoxycarb responsibly and in accordance with label instructions to minimize potential risks to human health and the environment.'

fenoxycarb: used against mosquitoes (Diptera:Culicidae); structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

fenoxycarb : A carbamate ester that is the O-ethyl carbamate of 2-(4-phenoxyphenoxy)ethylamine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID51605
CHEMBL ID15780
CHEBI ID5009
SCHEMBL ID27336
MeSH IDM0147883

Synonyms (65)

Synonym
abg 6215
ethyl (2-(p-phenoxy)ethyl)carbamate
fenoxycarb [bsi:iso]
ethyl(2-(p-phenoxyphenoxy)ethyl)carbamate
pictyl
varikill
fenoxycarb [ansi]
epa pesticide chemical code 125301
fenoxycarb [iso]
hsdb 6635
2-(4-(phenoxy-phenoxy)ethyl)carbamic acid ethyl ester
caswell no. 652c
carbamic acid, (2-(4-phenoxyphenoxy)ethyl)-, ethyl ester
pyctyl
ai3-29460
einecs 276-696-7
ro 13-5223
logic
ethyl (2-(4-phenoxyphenoxy)ethyl)carbamate
torus
carbamic acid, (2-(4-phenoxyphenyl)ethyl)-, ethyl ester
72490-01-8
fenoxycarb
NCGC00163823-02
CHEBI:5009 ,
79127-80-3
ethyl (2-(p-phenoxyphenoxy)ethyl)carbamate
o-ethyl n-[2-(4-phenoxyphenoxy)ethyl]carbamate
(2-(4-phenoxyphenoxy)ethyl)carbamic acid ethyl ester
n-(2-(p-phenoxyphenoxy)ethyl)carbamic acid
ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate
insegar
NCGC00163823-01
NCGC00163823-03
ethyl 2-(4-phenoxyphenoxy)ethylcarbamate
phenoxycarb
CHEMBL15780
hjuftijoisqskq-uhfffaoysa-
ethyl n-[2-[4-(phenoxy)phenoxy]ethyl]carbamate
inchi=1/c17h19no4/c1-2-20-17(19)18-12-13-21-14-8-10-16(11-9-14)22-15-6-4-3-5-7-15/h3-11h,2,12-13h2,1h3,(h,18,19)
ethyl n-[2-(4-phenoxyphenoxy)ethyl]carbamate
NCGC00163823-04
unii-jen0lsv1g9
jen0lsv1g9 ,
dtxsid7032393 ,
NCGC00254765-01
cas-72490-01-8
dtxcid5012393
tox21_301209
AKOS015917663
FT-0626260
carbamic acid, n-(2-(4-phenoxyphenoxy)ethyl)-, ethyl ester
eclipse
abg-6215
fenoxycarb [hsdb]
fenoxycarb [mi]
SCHEMBL27336
W-104487
carbamic acid,ethyl-,2-(4-phenoxyphenoxy)ethyl ester(9ci)
fenoxycarb, pestanal(r), analytical standard
fenoxycarb 10 microg/ml in acetonitrile
FT-0757929
Q415472
XCA49001
ethyl2-(4-phenoxyphenoxy)ethylcarbamate

Research Excerpts

Overview

Fenoxycarb is an insect growth regulator that mimics the action of methylfarnesoate. It promoted the production of 95% of male offspring at the given concentration.

ExcerptReferenceRelevance
"Fenoxycarb is an insect growth regulator that mimics the action of methylfarnesoate, and promoted the production of 95% of male offspring at the given concentration."( Assessment of the pesticides atrazine, endosulfan sulphate and chlorpyrifos for juvenoid-related endocrine activity using Daphnia magna.
Barbosa, IR; Bohn, A; Fernandes, RM; Matos, C; Palma, P; Palma, VL; Soares, AM, 2009
)
1.07

Actions

ExcerptReferenceRelevance
"The fenoxycarb was found to suppress the bombyxin (insulin-like peptides) secretion of cells in the spinning behavior on day 2."( Histological investigation of the effects of fenoxycarb on neurosecretory cells in the silkworm, Bombyx mori brain.
Tanriverdi O, E; Yelkovan, S, 2020
)
1.3

Treatment

Fenoxycarb was topically treated to the beginning of the fifth instar Bombyx larvae. L larvae showed higher susceptibility to Bt compared to the control larvae.

ExcerptReferenceRelevance
"The fenoxycarb-treated larvae showed higher susceptibility to Bt compared to the control larvae."( The endocrine disruptor, fenoxycarb modulates gut immunity and gut bacteria titer in the cotton bollworm, Helicoverpa armigera.
Attarianfar, M; Mehrabadi, M; Mikani, A, 2023
)
1.69
"Fenoxycarb was topically treated to the beginning of the fifth instar Bombyx larvae."( The effect of the juvenile hormone analog, fenoxycarb, on ecdysone receptor B1 expression in the midgut of Bombyx mori during larval-pupal metamorphosis.
Goncu, E; Parlak, O, 2012
)
1.36

Toxicity

ExcerptReferenceRelevance
" The only compound toxic to young mosquitofish at maximum field application rates was resmethrin."( Acute toxicity of mosquitocidal compounds to young mosquitofish, Gambusia affinis.
Hallmon, CF; Hester, PG; Olson, MA; Shaffer, KR; Tietze, NS, 1991
)
0.28
"The problems of developing sound and safe expert systems are discussed, with particular reference to medicine."( On the soundness and safety of expert systems.
Fox, J, 1993
)
0.29
" We demonstrate that induction of hemoglobin genes is a well-conserved response to JH even in the ovary, and a potential adverse effect of JH agonist is suppression of vitellogenin gene expression, that might cause reduction of offspring number."( Comparative ovarian microarray analysis of juvenile hormone-responsive genes in water flea Daphnia magna: potential targets for toxicity.
Iguchi, T; Sato, T; Tatarazako, N; Toyota, K; Williams, TD, 2017
)
0.46
" We aimed to explore the adverse effects of colonoscopy A&F using a feedback intervention theory (FIT) dark logic model before the National Endoscopy Database Automated Performance Reports to Improve Quality Outcomes Trial study."( Using a dark logic model to explore adverse effects in audit and feedback: a qualitative study of gaming in colonoscopy.
Bhardwaj-Gosling, R; Catlow, J; Rutter, MD; Sharp, L; Sniehotta, FF, 2022
)
0.72
"Our dark logic model highlighted that A&F interventions may create both desired and adverse effects."( Using a dark logic model to explore adverse effects in audit and feedback: a qualitative study of gaming in colonoscopy.
Bhardwaj-Gosling, R; Catlow, J; Rutter, MD; Sharp, L; Sniehotta, FF, 2022
)
0.72
"The study provides an in-depth view of factors contributing towards diversion of pharmaceutical opioids and can help guide national and international policy makers in their future initiatives to promote safe use of opioids in the management of chronic non-malignant pain in Pakistan."( Logic model for opioid safety in chronic non-malignant pain management, an in-depth qualitative study.
Anderson, C; Iqbal, A; Knaggs, R; Toh, LS, 2023
)
0.91
" Taken together, piericidin A was the most toxic and imidacloprid was the least toxic to hemocytes, and the alterations in hemocyte functions compromised immunity."( The immunotoxicity of ten insecticides against insect hemocyte cells in vitro.
Chen, Y; Huang, Q; Xu, J; Yan, D, 2022
)
0.72
"Under the framework of a hybrid-index model, this paper investigates safe control problems of state-dependent random impulsive logical control networks (RILCNs) on both finite and infinite horizons, respectively."( Safe control of logical control networks with random impulses.
Guo, Y; Liu, X; Sun, Z; Wang, Y; Zhou, R, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
" A pharmacodynamic model was developed that included three critical proteins (phospho-NFκB, BclxL, and cleaved poly (ADP ribose) polymerase)."( Logic-Based and Cellular Pharmacodynamic Modeling of Bortezomib Responses in U266 Human Myeloma Cells.
Abernethy, DR; Chudasama, VL; Mager, DE; Ovacik, MA, 2015
)
0.42

Compound-Compound Interactions

ExcerptReferenceRelevance
"Identifying drug-drug interactions (DDIs) is a critical process in drug administration and drug development."( Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism.
Anwar, S; Baral, C; Cai, J; Liang, S; Tari, L, 2010
)
0.36
" Here, we build a three-input cascade logic gate based on the advantages of biomolecules, particularly DNA, in the construction of computational logic systems, combined with metal ions and graphene oxide (GO)."( Developing a three-input cascade DNA logic gate based on the biological characteristics of metal ion-GO, combined with analysis and verification.
Cheng, M; Dong, Y; Hu, M; Niu, L; Wang, L; Wang, Y; Xi, S, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
"The aim of this study was to offer data about the bioavailability of flufenoxuron, lufenuron, pyriproxyfen and fenoxycarb in common commodities like mandarin, apricot and peach."( Bioavailability of insect growth regulators in citrus and stone fruits.
Barba, A; Camara, MA; Mulero, J; Oliva, J; Paya, P; Zafrilla, P, 2007
)
0.55
" The bioavailability of wines obtained from grapes in each assay and in standard solutions is also studied in order to establish matrix-related differences."( Influence of the matrix in bioavailability of flufenoxuron, lufenuron, pyriproxyfen and fenoxycarb residues in grapes and wine.
Barba, A; Cámara, MA; Mulero, J; Oliva, J; Payá, P, 2013
)
0.61

Dosage Studied

ExcerptRelevanceReference
" Dosage is limited by a reduction in respiratory rate, and by a series of electronic fail-safe circuits."( Control of postoperative pain by interactive demand analgesia.
Hull, CJ; Sibbald, A, 1981
)
0.26
"The International Commission on Radiological Protection (ICRP) continues to accept the assumption of a linear non-threshold dose-response relationship (LNT) as the most likely one."( Logic and ethics in radiation protection.
Lindell, B, 2001
)
0.31
" Causal inference in epidemiology consists in checking the logical coherence of a causality statement and determining whether what has been found grossly contradicts what we think we already know: how strong is the association? Is there a dose-response relationship? Does the cause precede the effect? Is the effect biologically plausible? Etc."( Epidemiological causality.
Morabia, A, 2005
)
0.33
"The physical-chemical properties of interest for controlled release (CR) dosage form development presented are based on the author's experience."( Preformulation considerations for controlled release dosage forms. Part I. Selecting candidates.
Chrzanowski, F, 2008
)
0.35
" The fold changes of CUT and VTG mRNA expression showed significant dose-response relationship with FOC exposure."( Determination of mRNA expression of DMRT93B, vitellogenin, and cuticle 12 in Daphnia magna and their biomarker potential for endocrine disruption.
Choi, K; Chung, WJ; Kim, J; Kim, Y; Kwak, K; Lee, S, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
juvenile hormone mimicnull
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
insecticideStrictly, a substance intended to kill members of the class Insecta. In common usage, any substance used for preventing, destroying, repelling or controlling insects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (24)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency31.70550.007215.758889.3584AID1224835
pregnane X receptorRattus norvegicus (Norway rat)Potency50.11870.025127.9203501.1870AID651751
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency38.89523.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency45.00330.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency24.49790.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency32.70540.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743042; AID743054; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency24.33650.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency31.22260.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency17.22890.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency25.53860.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency28.18380.000817.505159.3239AID588544
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency25.13570.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency35.90430.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency43.08960.000229.305416,493.5996AID1259244; AID1259248; AID588513; AID588514; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency38.89520.001019.414170.9645AID743191
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency76.95880.001723.839378.1014AID743083
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency61.644819.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency48.96620.057821.109761.2679AID1159526
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency61.13060.000323.4451159.6830AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency17.50230.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency27.71700.00798.23321,122.0200AID2546; AID2551
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency43.27710.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency83.34240.002319.595674.0614AID651631; AID651743
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency43.27710.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (20)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (28)

Assay IDTitleYearJournalArticle
AID1091972Inhibition of metamorphosis in freshly molted Pyrrhocoris apterus (red firebug) fourth-instar nymph assessed as compound dose per individual causing reduction in metamorphosis by oral drinking assay2010Bioorganic & medicinal chemistry, Dec-01, Volume: 18, Issue:23
Steroid conjugates: Synthesis and preliminary biological testing of pro-juvenoids.
AID1105539Juvenile hormone mimicking activity against Bemisia tabaci (sweet potato whitefly) infested cotton assessed as suppression of nymph emergence at 100 g/ha applied as wettable powder through spray measured on day 12 under field conditions (Rvb = 92%)1996Archives of insect biochemistry and physiology, , Volume: 32, Issue:3-4
Projuvenoids: synthesis and biological evaluation of sulfenylated, sulfinylated, and sulfonylated carbamates.
AID1105530Lipophilicity, log P of the compound1996Archives of insect biochemistry and physiology, , Volume: 32, Issue:3-4
Projuvenoids: synthesis and biological evaluation of sulfenylated, sulfinylated, and sulfonylated carbamates.
AID1111260Insecticidal activity against adult of Cacopsylla melanoneura in apple plant assessed as reduction of progeny per female at 187.5 g/ha treated for 1 hr measured after 7 days2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID1111254Insecticidal activity against adult of Cacopsylla melanoneura in apple plant assessed as reduction of progeny per female at 187.5 g/ha treated for 14 days measured after 7 days2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID468443Inhibition of human FAAH at 1 uM2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
AID1105538Juvenile hormone mimicking activity against Bemisia tabaci (sweet potato whitefly) infested cotton assessed as suppression of nymph emergence at 200 g/ha applied as wettable powder through spray measured on day 12 under field conditions (Rvb = 92%)1996Archives of insect biochemistry and physiology, , Volume: 32, Issue:3-4
Projuvenoids: synthesis and biological evaluation of sulfenylated, sulfinylated, and sulfonylated carbamates.
AID1111256Insecticidal activity against adult of Cacopsylla melanoneura in apple plant assessed as overwintered female mortality at 187.5 g/ha treated for 14 days measured after 1 day relative to control2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID1111258Insecticidal activity against adult of Cacopsylla melanoneura in apple plant assessed as overwintered female mortality at 187.5 g/ha treated for 7 days measured after 3 days relative to control2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID1111261Insecticidal activity against adult of Cacopsylla melanoneura in apple plant assessed as overwintered female mortality at 187.5 g/ha treated for 1 hr measured after 3 days relative to control2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID1105546Juvenile hormone mimicking activity against fifth-instar larval stage of Pieris brassicae reared on cabbage plants assessed as morphogenetic changes measured per larvae applied topically to dorsal surface of larvae measured post pupal ecdysis1996Archives of insect biochemistry and physiology, , Volume: 32, Issue:3-4
Projuvenoids: synthesis and biological evaluation of sulfenylated, sulfinylated, and sulfonylated carbamates.
AID1111257Insecticidal activity against adult of Cacopsylla melanoneura in apple plant assessed as reduction of progeny per female at 187.5 g/ha treated for 7 days measured after 7 days2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID1105531Juvenile hormone mimicking activity against Bemisia tabaci (sweet potato whitefly) infested cotton assessed as suppression of adult emergence at 400 g/ha applied as wettable powder through spray measured on day 12 under field conditions (Rvb = 89%)1996Archives of insect biochemistry and physiology, , Volume: 32, Issue:3-4
Projuvenoids: synthesis and biological evaluation of sulfenylated, sulfinylated, and sulfonylated carbamates.
AID1105537Juvenile hormone mimicking activity against Bemisia tabaci (sweet potato whitefly) infested cotton assessed as suppression of nymph emergence at 400 g/ha applied as wettable powder through spray measured on day 12 under field conditions (Rvb = 92%)1996Archives of insect biochemistry and physiology, , Volume: 32, Issue:3-4
Projuvenoids: synthesis and biological evaluation of sulfenylated, sulfinylated, and sulfonylated carbamates.
AID1111255Insecticidal activity against adult of Cacopsylla melanoneura in apple plant assessed as overwintered female mortality at 187.5 g/ha treated for 14 days measured after 3 days relative to control2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID1091973Inhibition of metamorphosis in freshly molted Pyrrhocoris apterus (red firebug) fifth-instar nymph assessed as compound dose per individual causing reduction in metamorphosis by topical screening test2010Bioorganic & medicinal chemistry, Dec-01, Volume: 18, Issue:23
Steroid conjugates: Synthesis and preliminary biological testing of pro-juvenoids.
AID1105532Juvenile hormone mimicking activity against Bemisia tabaci (sweet potato whitefly) infested cotton assessed as suppression of adult emergence at 200 g/ha applied as wettable powder through spray measured on day 12 under field conditions (Rvb = 89%)1996Archives of insect biochemistry and physiology, , Volume: 32, Issue:3-4
Projuvenoids: synthesis and biological evaluation of sulfenylated, sulfinylated, and sulfonylated carbamates.
AID1100711Ovicidal activity against 24 hr old Cydia pomonella (codling moth) eggs assessed as efficacy at 5 mg/ml sprayed at 19 +/- 1 degC2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Synthesis of phenoxyphenyl pyridine and pyrazine carboxamides. Activity against Cydia pomonella (L.) eggs.
AID1111227Insecticidal activity against young stage of Cacopsylla melanoneura in apple plant assessed as mortality at 187.5 g/ha treated for 14 days measured after 7 days relative to control2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID1100710Ovicidal activity against 24 hr old Cydia pomonella (codling moth) eggs assessed as mortality at 5 mg/ml sprayed at 19 +/- 1 degC2000Journal of agricultural and food chemistry, Jan, Volume: 48, Issue:1
Synthesis of phenoxyphenyl pyridine and pyrazine carboxamides. Activity against Cydia pomonella (L.) eggs.
AID1105544Juvenile hormone mimicking activity against adult Sitophilus oryzae (rice weevil) infested wheat kernels assessed as suppression of progeny development at 1 ppm applied through diet for 21 days measured after 9 weeks1996Archives of insect biochemistry and physiology, , Volume: 32, Issue:3-4
Projuvenoids: synthesis and biological evaluation of sulfenylated, sulfinylated, and sulfonylated carbamates.
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID1111228Insecticidal activity against young stage of Cacopsylla melanoneura in apple plant assessed as mortality at 187.5 g/ha treated for 7 days measured after 7 days relative to control2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID1111229Insecticidal activity against young stage of Cacopsylla melanoneura in apple plant assessed as mortality at 187.5 g/ha treated for 1 hr measured after 7 days relative to control2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID1080666Ovicidal activity against <24 hr-old Cydia pomonella (codling moth) eggs assessed as corrected mortality at 0.5 mg/ml applied as 0.1 ul drop solution topically measured for 3 days2009Journal of agricultural and food chemistry, Jun-10, Volume: 57, Issue:11
Synthesis of allyl esters of fatty acids and their ovicidal effect on Cydia pomonella (L.).
AID1105533Juvenile hormone mimicking activity against Bemisia tabaci (sweet potato whitefly) infested cotton assessed as suppression of adult emergence at 100 g/ha applied as wettable powder through spray measured on day 12 under field conditions (Rvb = 89%)1996Archives of insect biochemistry and physiology, , Volume: 32, Issue:3-4
Projuvenoids: synthesis and biological evaluation of sulfenylated, sulfinylated, and sulfonylated carbamates.
AID1111259Insecticidal activity against adult of Cacopsylla melanoneura in apple plant assessed as overwintered female mortality at 187.5 g/ha treated for 7 days measured after 1 day relative to control2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
AID1111262Insecticidal activity against adult of Cacopsylla melanoneura in apple plant assessed as overwintered female mortality at 187.5 g/ha treated for 1 hr measured after 1 day relative to control2010Pest management science, Mar, Volume: 66, Issue:3
Effectiveness of five insecticides for the control of adults and young stages of Cacopsylla melanoneura (Förster) (Hemiptera: Psyllidae) in a semi-field trial.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4,050)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990846 (20.89)18.7374
1990's590 (14.57)18.2507
2000's925 (22.84)29.6817
2010's1079 (26.64)24.3611
2020's610 (15.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.74 (24.57)
Research Supply Index8.41 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index65.13 (26.88)
Search Engine Supply Index3.22 (0.95)

This Compound (27.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials91 (2.07%)5.53%
Reviews459 (10.46%)6.00%
Case Studies57 (1.30%)4.05%
Observational5 (0.11%)0.25%
Other3,775 (86.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]